ResultsIQ

ResultsIQ › Latest results › Novartis India Limited

Novartis India Limited investor meet summary

NSE: NOVARTIND · BSE: 500672

Investor meet of 11 Sep 2026, summarised by AI from the filing.

Novartis India targets at least doubling revenue in four to five years, with near-term cost impact from commercial reset.

Key takeaways

  1. Revenue trend Company has been flattish in revenue and PAT over the last four years.
  2. Guidance At least doubling revenue in next four to five years, organically.
  3. Change New ownership by ChrysCapital with 70.68% stake; new board and management team.
  4. Risk Transition plan will incur near-term costs and one-time costs, impacting profitability.

Original filing on BSE

Novartis India Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.